ArticleMedical archives (Sarajevo, Bosnia and Herzegovina)2023
Adjuvant Intravesical Chemotherapy Versus Immunotherapy for All Risk Groups of Patients With Non-muscle Invasive Bladder Cancer.
Haris Djug et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.